Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Teleste: Managers´ transactions – Harju, Esa

Teleste CorporationManagers´ transactionsApril 3, 2023, at 9:30 a.m. EEST TELESTE: MANAGERS´ TRANSACTIONS – HARJU, ESA   Teleste Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Esa Harju Position: Chief Executive Officer  Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 28232/5/4 ____________________________________________ Transaction date: 2023-03-31 Outside a trading venue Instrument type: SHARE ISIN:

The recipe of Fazer’s beloved Geisha chocolate is changing: “We are responding to consumers’ wishes”

Fazer Geisha has been among Finns’ favourite chocolates since the 1960s, and now its recipe is being updated. Palm oil in the Geisha chocolate filling will become a thing of the past as, moving forward, it will be replaced by sustainably produced cocoa butter.The word “Geisha” refers to artist in Japanese. “Gei” means “art” and “sha” a skilled person. The updating of the recipe has also required skills and expertise. Cocoa butter proved to be the solution for updating the recipe without compromising the familiar soft flavour and texture. The Geisha recipe update is part of Fazer’s

Teleste: Managers´ transactions – Hyytiäinen, Juha

Teleste CorporationManagers´ transactionsApril 3, 2023, at 9:30 a.m. EEST TELESTE: MANAGERS´ TRANSACTIONS – HYYTIÄINEN, JUHA   Teleste Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Juha Hyytiäinen Position: Chief Financial Officer  Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 28229/7/14____________________________________________ Transaction date: 2023-03-31 Outside a trading venue Instrument type: SHARE

Teleste: Managers´ transactions – Narjus, Hanno

Teleste CorporationManagers´ transactionsApril 3, 2023, at 9:30 a.m. EEST TELESTE: MANAGERS´ TRANSACTIONS – NARJUS, HANNO   Teleste Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Hanno Narjus Position: Other senior manager  Issuer: Teleste Oyj LEI: 743700CJRQRU0007GN59 Notification type: INITIAL NOTIFICATION Reference number: 28235/5/4 ____________________________________________ Transaction date: 2023-03-31 Outside a trading venue Instrument type: SHARE ISIN:

Ovzon expands its offering with partner Nigma Conseil through a follow-up order

Ovzon expands its On-the-Move (OTM) SATCOM-as-a-Service offering with the partner Nigma Conseil through an initial order at a value of MUSD 0.6. The order includes both industry-leading OTM terminals and dedicated solutions development and support.Ovzon received its first order from Nigma Conseil in December 2022 with an order value of MUSD 1. This follow-up order demonstrates Nigma’s dedication as a valued partner in bringing Ovzon solutions to customers with demanding and critical missions. The deliveries contain the newest variants of Ovzon’s OTM terminals, including technology and

XNK Receives EU Tissue Establishment Certificate

XNK Therapeutics today announced that it has been approved as an EU Tissue Establishment. This certificate allows the company to take control of the complete manufacturing chain, from withdrawal of blood from the patient at the clinic to the delivery of the finished autologous NK-cell based medicinal product.“This is another very important milestone for us. From a manufacturing viewpoint, we now have all the permits we need to launch clinical studies within EU. All building blocks are now completed to position us for significant value creation with three to four potential phase I/II

Ultomiris recommended for NMOSD EU approval

3 April 2023 07:00 BST   Ultomiris recommended for approval in the EU by CHMP for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)   No relapses observed in pivotal trial of first and only long-acting C5 inhibitor, indicating potential to prevent long-term disability due to relapses   Ultomiris (ravulizumab) has been recommended for marketing authorisation in the European Union (EU) for the treatment of adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive (Ab+). If authorised,

BioStock Investor Pitch: ExpreS2ion Biotechnologies

Danish ExpreS2ion Biotechnologies develops a portfolio of vaccines currently targeting Covid-19, breast cancer, influenza, malaria and, with the latest pipeline addition, the cytomegalovirus. The company is currently looking to raise 102 MSEK in a rights issue to finance the next step with the ES2B-C001 breast cancer vaccine. CEO Bent U. Frandsen tells us more about the ongoing activities in  BioStock Investor Pitch today at 08.45 am.See the presentation at biostock.se : https://www.biostock.se/2023/04/biostock-investor-pitch-expres2ion-biotechnologies-2/

AMF has assumed its ownership in Delcore Fastigheter

AMF assumed its ownership in Delcore Fastigheter on 1 April 2023.Delcore Fastigheter is a company that is jointly owned by ICA Real Estate and the occupational pensions company AMF, as announced by ICA Gruppen on 23 December 2022, see press release . The net effect of the transaction on the Group’s cash flow will be approximately SEK 3.8 billion during the second quarter of 2023. At the same time, the Group’s net debt (excluding ICA Bank and IFRS 16 lease liabilities) will

New lecanemab-data presented at the AD/PD™ 2023 conference

Stockholm, April 3, 2023 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and its partner Eisai has presented new findings on lecanemab (generic name, U.S. brand name: LEQEMBI™), an anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer’s disease (AD), at the 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders (AD/PD™). The presentations included analyses of amyloid-related imaging abnormalities (ARIAs) with antiplatelet and anticoagulant therapy, the incidence of isolated ARIA-H, and health-related quality of life (QOL),

Presentation of Intrum’s results for January-March 2023

Intrum announces its interim results for January-March 2023 on 27 April at 7:00 a.m. CET. The report will be presented in an audiocast with teleconference at 9.00 a.m. CET the same day.At the audiocast, Intrum will be represented by Andrés Rubio, President & CEO, and Michael Ladurner, CFO. The presentation will be held in English. To participate via audiocast, please use this link . Via the audiocast you will be able to ask written questions. To participate via teleconference, please register here 

DanCann Pharma A/S presented their work to the Ministry of Foreign Affairs

COPENHAGEN, Denmark, April 03, 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or "the Company"), a Danish company powered by cannabinoids, hereby announces that on March 30th, the Company received a visit from the Ministry of Foreign Affairs, represented by the Danish export manager, a senior adviser from the embassy in the Czech Republic, and the head of the health department.Jeppe Krog Rasmussen, Louise Conradsen, and Morten Martinsen welcomed the Ministry of Foreign Affairs along with the rest of the DanCann Pharma team to their facility in Jutland. The purpose

Ranplan publishes the Annual Report for 2022

Cambridge UK, 3 April 2023 – Ranplan’s Annual Report for 2022 has been published. A copy of the document in English or Swedish is available under Investors/Financial on the company’s website, please see www.ranplanwireless.com/investors. For further information, please contact:Per Lindberg, CEOTel: +46 79 340 7592per.lindberg@ranplanwireless.comwww.ranplanwireless.com Certified AdviserFNCA Sweden AB, info@fnca.se, is the Company’s Certified Adviser at Nasdaq First North. The information was submitted for publication, through the agency of the contact person above, on 3

Orexo shares new timeline for the high-dose rescue medication for opioid overdose, OX124

Uppsala, Sweden – April 3, 2023 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces the expected US launch of OX124, a high-dose rescue medication for opioid overdose, is delayed to late 2024 from previously first half of 2024, if approved by the US Food and Drug Administration (FDA) according to their ordinary timelines.   The updated timeline follows unexpected technical issues with the equipment used for the secondary packaging process in the outsourced supply chain for OX124 and there is a need for qualification and documentation of the packaging process to meet the

Metso Outotec complements its screening media offering with Trellex® GS modular panel

Metso Outotec Corporation’s press release on April 3, 2023, at 09:00 a.m. EESTMetso Outotec expands its screening media offering with Trellex® GS, a panel that meets European aggregate industry fixing standards. Trellex® GS is an innovative, modular screening media with a knock-in system available in both rubber and polyurethane. It is designed to offer long wear life, with easier change-outs and increased uptime and safety. The new screening media panel is now commercially available. ”Trellex® GS is an important addition to Metso Outotec’s screening media portfolio and complements our

Sobi® publishes Annual and sustainability report for 2022

Under the header of ‘Inspired by caring, powered by science’, Sobi® today published its Annual and sustainability report for 2022 with several improvements and new features.   The integrated report includes the audited Annual report and the Sustainability report which is Sobi’s statutory sustainability report in accordance with the Swedish Annual Accounts Act and based on GRI Standards 2021. The Sustainability report also includes Sobi’s Task Force on Climate-related Financial Disclosures report and the new EU taxonomy disclosures.   Sobi® Sobi is a specialised international

Teleste Corporation´s conveyance of own shares based on the long-term incentive plan

Teleste CorporationStock exchange releaseApril 3, 2023, at 9:00 a.m. EEST   TELESTE CORPORATION´S CONVEYANCE OF OWN SHARES BASED ON THE LONG-TERM INCENTIVE PLAN   A total of 10,656 Teleste Corporation's treasury shares were conveyed without consideration to the key employees participating in the plan periods 2020-2022 and 2021-2023 of Teleste long-term share-based incentive programme. More detailed information about the launch of the plan periods and their terms and conditions is available in a stock exchange releases published on 13 February 2020 and 11 February 2021.

Notice of Annual General Meeting in Inwido AB

The shareholders of Inwido AB (publ), Reg. No. 556633-3828, are hereby invited to attend the Annual General Meeting (“AGM”) to be held on Thursday 4 May 2023 at 15.00 CEST at Studio, Nordenskiolsdagatan 24, 211 19 Malmö, Sweden. Registration of attendance commences at 14.30 CEST. The notice is available at www.inwido.com where shareholders also can notify the company of their intention to attend the AGM. Complete documentation for the AGM will be available at Inwido’s head office and on www.inwido.com no later than from Thursday 13 April 2023.The Board of Directors has decided that

Readly achieves seventy percent of its sustainability target

Digital magazine and newspaper app Readly has announced its latest Sustainability Report with insights into the environmental, social and governance performance (ESG) during the past year. The highlights include a 24 percent lower travel emission intensity per employee and an 8 percent increase of emissions saved from digital reading on Readly in comparison to the previous year. Overall, 70 percent of Readly’s sustainability goals were fulfilled in 2022.   – The majority of our subscribers believe it is important that their reading habits are as environmentally friendly as

Florian Nowotny to resign as CEO of DDM

DDM Debt AB (publ) (Nasdaq Stockholm: DDM Debt 2026) ("DDM Debt") announces that Florian Nowotny has informed the Board that he has decided to step down from his position as CEO. The Board of Directors thanks Mr. Nowotny for his commitment and his valuable contribution to the Company. Dr. Andreas Tuczka (Chairman of the Board of Directors) will assume the role of Executive Chairman on an interim basis and lead the company together with Fredrik Olsson, Chief Financial Officer, and Alessandro Pappalardo, Chief Investment Officer, until a permanent CEO-successor is announced. Florian

Florian Nowotny to resign as CEO of DDM

DDM Holding AG (First North Growth Market: DDM) announces that Florian Nowotny has informed the Board that he has decided to step down from his position as CEO. The Board of Directors thanks Mr. Nowotny for his commitment and his valuable contribution to the Company. Dr. Andreas Tuczka (Chairman of the Board of Directors) will assume the role of Executive Chairman on an interim basis and lead the company together with Fredrik Olsson, Chief Financial Officer, and Alessandro Pappalardo, Chief Investment Officer, until a permanent CEO-successor is announced. Florian Nowotny has agreed to

SAS MAKES IT EASIER TO CHOOSE BIOFUEL

On April 3, SAS launches two ticket types that include biofuel. These will be available on all SAS domestic, Scandinavian and European flights.SAS aims to use fossil-free aviation fuel equivalent of all our domestic flights by 2030, a journey we make together with our passengers. We are, therefore, making it even easier for our travelers to be part of the journey toward more sustainable air travel by launching tickets that include the maximum allowed amount of biofuel. Travelers buying Go Smart or Plus Pro tickets will be able to purchase th  ese tickets with approximately 50%* of

Akobo Minerals starts up operation of ultra-small plant to process first gold

OSLO, 03 April 2023: Akobo Minerals AB (publ) (Euronext and Frankfurt: AKOBO), the Scandinavian-based Ethiopian gold exploration and boutique mining company, today announced that it has reached a true milestone with the start of operations of its ultra-small plant and, with it, production of the company’s first gold.       Key highlights  · Operational start-up acting as proof of concept · Early test production commenced with washed out tailings · Gold seen from first processed material – though with limited economic value · Learning and preparation process for main

There are no items matching the current filter
There are no more items matching the current filter
Back to top